Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.
about
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinomaTreatment for Barrett's oesophagusBarrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesisEarly events during neoplastic progression in Barrett's esophagusEpidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this diseaseBarrett's oesophagus: frequency and prediction of dysplasia and cancerUse of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancersLife history trade-offs in cancer evolutionNSAIDs modulate clonal evolution in Barrett's esophagus.Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysisExercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus.Low grade dysplasia in Barrett's esophagus: Should we worry?Evidence for DNA damage checkpoint activation in barrett esophagusRisk factors for the development of oesophageal adenocarcinoma in Barrett's oesophagus: a UK primary care retrospective nested case-control study.Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.Barrett's esophagus and cancer risk: how research advances can impact clinical practice.Effect of medical and surgical treatment of Barrett's metaplasiaThe use of animal models for cancer chemoprevention drug developmentRisk factors and chemoprevention in Barrett's esophagus--an update.Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants.Chemoprevention of esophageal adenocarcinomaAre We Making Progress in Preventing Barrett's-Related Esophageal Cancer?Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagusInflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort.The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagusThe incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP studyReduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition.Deletion at fragile sites is a common and early event in Barrett's esophagus.Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus.NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical managementPrecision prevention of oesophageal adenocarcinoma.Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.American Gastroenterological Association technical review on the management of Barrett's esophagusGenetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans.Obesity and inflammation markers in relation to leukocyte telomere length in a cross-sectional study of persons with Barrett's esophagusUse of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.
P2860
Q21563424-207C79AE-5261-4174-9913-9193E1F8C807Q24240701-D6074F38-A7AB-492E-8A42-C5C6D7083857Q24602426-16EB6E97-493C-4751-A4D3-9E4452452403Q26825349-305481DE-E44F-4408-BB49-6422F0305040Q27027061-CFB51895-C4BB-4C94-AB26-D293A793A446Q28080794-6AEA5F43-2375-4DAD-AA51-255CD2405350Q28218710-D46E934C-4401-475A-B14D-A9767E00A5C8Q28657962-5070852D-6EAA-4B20-BB17-D67E1D0EBFFCQ31119674-E31B6BA1-39EF-4975-A256-4686447C7E44Q33555216-50F77D92-EF18-4429-B18A-D9B335940340Q33605428-B26A348A-E15E-40D8-981F-F8BBDA46E2BFQ33628118-27F18388-528C-4254-9ABA-3332E3585BB6Q33655360-7C9B1912-F131-41AC-BB8F-EA8B8275669DQ33695661-768EFF52-F231-406A-B67E-C328BA662323Q33707944-0A67CF40-87F7-43A4-B30A-45311048ED24Q33786336-76F067A6-0AFA-4BAE-A997-9F6A9644B12CQ33905941-AFFB5E6E-7CFC-4F75-860C-03655ABC149FQ33959620-D892F0D2-0162-48A5-A24C-872D8E7BF1F7Q34063700-64CBC4C0-DBC2-4FB3-9956-137A9612221BQ34112475-93570812-13C3-4B46-8712-FC231E92F307Q34201351-E29589BB-7AA7-4D41-9622-AD96275D18F0Q34310309-F4DABBCA-D5ED-4215-9D2B-BC20879BFA24Q34408890-509695FB-E658-4807-BD64-8C5B336D321CQ34408973-175947B0-1A90-4BDB-8F53-73959E5CF32FQ34429198-CD1FCF45-AF96-471B-86CD-6C4BCA477504Q34457732-459EBC19-042B-4C1A-AEC7-42D3C78D03F8Q34542075-5D696E74-AEF5-49B7-A983-62AC90EB58B9Q34786281-EE4BEBED-F5B8-4385-ACCA-31F66058267CQ34797536-DC83F3C0-BF98-4656-B9DB-03075D85C9B9Q34898182-F5254BC1-EB92-445A-B87A-E630B50143C5Q35002032-EA057063-DC3B-40A3-9161-FEEBF523785EQ35007536-3ACB1944-FCD2-4FDE-A9E2-2E18B1F2AFDAQ35046884-169842FF-5A3E-4E85-AC8A-7AA7FD638034Q35057339-3BA5D087-4CFB-4F14-B2C1-6357A5B71207Q35243217-4A591561-7177-42D8-967B-41C029A4D01FQ35666515-E53C6A6E-0A68-46AE-ACF0-83958E171C3FQ35673305-E4BBC5B6-E674-48F0-A788-46A4A76B8FB7Q35753199-8980FA29-081F-4B2F-94FD-7ADCC10BD3CFQ35778939-36D4B866-65F4-40B7-A9FC-2D62C1B4A6A7Q35815590-E6081E13-B3BB-489E-8858-C6C9733C6A82
P2860
Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Non-steroidal anti-inflammator ...... sophagus: a prospective study.
@ast
Non-steroidal anti-inflammator ...... sophagus: a prospective study.
@en
Non-steroidal anti-inflammator ...... sophagus: a prospective study.
@nl
type
label
Non-steroidal anti-inflammator ...... sophagus: a prospective study.
@ast
Non-steroidal anti-inflammator ...... sophagus: a prospective study.
@en
Non-steroidal anti-inflammator ...... sophagus: a prospective study.
@nl
prefLabel
Non-steroidal anti-inflammator ...... sophagus: a prospective study.
@ast
Non-steroidal anti-inflammator ...... sophagus: a prospective study.
@en
Non-steroidal anti-inflammator ...... sophagus: a prospective study.
@nl
P2093
P1433
P1476
Non-steroidal anti-inflammator ...... sophagus: a prospective study.
@en
P2093
Brian J Reid
Carissa A Sanchez
Kamran Ayub
Linda M Dong
Peter S Rabinovitch
Robert D Odze
Thomas L Vaughan
P304
P356
10.1016/S1470-2045(05)70431-9
P577
2005-12-01T00:00:00Z